| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 02/16/2006 | US20060035260 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
| 02/16/2006 | US20060035238 Composition comprising an array which further comprises chimeric compositions |
| 02/15/2006 | EP1625141A2 Grp94-based compositions and methods of use thereof |
| 02/15/2006 | EP0762892B1 Diphtheria toxin vaccines bearing a mutated r domain |
| 02/15/2006 | CN1735422A Pept¿¼deos antimicrobianos de novispirin |
| 02/14/2006 | US6998470 by using diafiltration, solid phase extraction and immunoaffinity techniques |
| 02/14/2006 | US6998251 Arrays for use in high throughput assays, organic synthesis and combinatorial chemistry; microfluidics |
| 02/14/2006 | CA2247889C Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
| 02/09/2006 | US20060030696 Protein a chromatography |
| 02/09/2006 | US20060029966 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/09/2006 | DE102004031258A1 Proteinhybride mit polyhydroxyaromatischen Aminosäure-Epitopen Protein hybrids with polyhydroxy aromatic amino acid epitopes |
| 02/09/2006 | DE10002895B4 Koimmobilisierung mehrerer chemischer Spezies Co-immobilization of multiple chemical species |
| 02/09/2006 | CA2572618A1 Taxol immunoassay |
| 02/08/2006 | CN1732185A Method for the crystallization of human serum albumin |
| 02/08/2006 | CN1730494A Cobratide modified by polyethylene glycol, its preparation method and uses |
| 02/07/2006 | US6995248 Bipolymer for use in the generation of solid support |
| 02/07/2006 | US6995241 Acute Neuronal Induced Calcium-Binding Protein (ANIC-BP-1B) polypeptides and polynucleotides; diagnostic assays; neuroprotectants; agonists; antagonists; stroke , Parkinson's disease, Alzheimer disease, multiple sclerosis and spinal cord injuries |
| 02/07/2006 | US6994970 Peptides which bind auto-antibodies for use in extracorporeal treatment; peptides bound to solid support for chromatography; specified amino acid sequence |
| 02/02/2006 | US20060025573 Reducing the immunogenicity of fusion proteins |
| 02/02/2006 | US20060024371 Crosslinking a protein with derivative of a hydrophilic polymer with a functionality of at least three to form a non-liquid hydrogel and incorporating a therapeutic agent; the hydrogel degrades over time back to a liquid form |
| 02/01/2006 | CN1727471A Application of alcohol soluble film in protein ground substance from source of plants |
| 01/31/2006 | US6992180 Oligo- or polynucleotides comprising phosphate-moiety labeled nucleotides |
| 01/31/2006 | US6992177 haptens comprising protease inhibitors such as succinimido-oxycarbonyl-ethylamino-glycyl-glycyl-glutaryl-aminomethyl-(pyr)saquinavir conjugates with hemocyanins, albumin or dextran, used to generate antibodies and immunogens to saquinavir; assays |
| 01/31/2006 | US6992174 Reducing the immunogenicity of fusion proteins |
| 01/31/2006 | US6992171 Polypeptide and its DNA |
| 01/31/2006 | US6991911 for detection of 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-methamphetamine (MDMA) anibody production; drug screening; haptens; immunogens |
| 01/31/2006 | US6991796 Platlet glycoprotein IBα fusion polypeptides and methods of use thereof |
| 01/31/2006 | US6991785 Administering by tissue absorption |
| 01/26/2006 | WO2006008386A1 Bioactive biomaterials for controlled delivery of active principles |
| 01/26/2006 | WO2004013160A3 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 01/26/2006 | US20060019877 Hasylated polypeptides |
| 01/26/2006 | US20060019309 Self-assembling peptide surfaces for cell patterning and interactions |
| 01/26/2006 | US20060019287 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/26/2006 | DE10142743B4 Biochips mit Dimorphismus-spezifischen Faktoren aus Candida albicans Biochips with dimorphism-specific factors of Candida albicans |
| 01/26/2006 | CA2574085A1 Gonadotropin releasing hormone antagonists |
| 01/25/2006 | EP1617854A2 Biologically active native biomatrix composition |
| 01/24/2006 | US6989436 Stabilization of cardiac troponin I subunits and complexes |
| 01/24/2006 | US6989254 Direct encapsulation of biomacromolecules in surfactant templated mesoporous and nanoporous materials |
| 01/19/2006 | US20060014926 Human papillomavirus E6 and E7 polypeptides, mutant polypeptide retains 30% of the immunogenicity of an isolated polypeptide comprising human wild-type papillomavirus E6 and E7 |
| 01/19/2006 | US20060014692 Methods of using non-human animal Apoliprotein A-I protein |
| 01/19/2006 | US20060014177 A sample storage substrate comprising an elastomeric substrate made of open cell foam, closed cell foam, or a combination thereof and a biological sample absorbed by the elastomeric substrate; resists degradation |
| 01/19/2006 | US20060014156 Nucleic acid detecting or quantifying processes |
| 01/18/2006 | EP1511760B1 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides |
| 01/18/2006 | EP1337325B1 Acoustic ejection of fluids from a plurality of reservoirs |
| 01/18/2006 | EP1071442B9 Methods and compositions for peptide synthesis (t-20) |
| 01/18/2006 | CN1721447A Modified peptides as therapeutic agents |
| 01/17/2006 | US6987170 Cloning and expression of recombinant adhesive protein Mefp-1 of the blue mussel, Mytilus edulis |
| 01/17/2006 | US6987168 Tryptase inhibitor proteins derived from blood-feeding anthropod ectoparasites |
| 01/17/2006 | US6987167 Process for production of the somatostatin analog, octreotide |
| 01/17/2006 | US6987022 Lectin protein derived from Dolichos beans or soybeans; and a physiologically inert carrier material in the form of beads |
| 01/17/2006 | US6987016 α-galactosidases and methods for making and using them |
| 01/12/2006 | US20060008901 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/12/2006 | CA2572707A1 Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof |
| 01/12/2006 | CA2570253A1 Process for producing protein a-like protein with use of brevibacillus genus bacaterium |
| 01/11/2006 | EP1614694A1 Titanium dioxide complex having molecule distinguishability |
| 01/11/2006 | EP1613338A2 Tamandarin analogs and fragments thereof and methods of making and using |
| 01/11/2006 | CN1235910C Target-specific cytotoxin chimeric with short-peptide harmone |
| 01/10/2006 | US6984486 Synthetic peptide of regulatory virus protein R (VPR) of human immunodeficiency virus type 1 (HIV-1) and the utilization thereof |
| 01/05/2006 | US20060004184 Method and device for detecting feline immunodeficiency virus |
| 01/05/2006 | US20060003386 Metallopeptide combinatorial libraries and applications |
| 01/05/2006 | US20060003355 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/05/2006 | DE102005023474A1 Hydrophilic support material for analyzing or isolating antibodies, comprises immobilized protein A that is covalently bonded to a hydrophilic support material via a spacer |
| 01/05/2006 | CA2571034A1 New chiral columns with broad chiral selectivity |
| 01/03/2006 | US6982319 Protein for use in the treatment of liver disorders, fibrosis, cancer, rheumatoid arthritis and glomeronephritis |
| 01/03/2006 | US6982250 Methods of prevention and treatment of inflammatory bowel disease |
| 01/03/2006 | US6982149 Fiber array and methods for using and making same |
| 12/30/2005 | CA2511084A1 Carbohydrate-phosphorylcholine conjugate molecules and their use in vaccinal, therapeutic and diagnostic applications |
| 12/29/2005 | WO2005046587A3 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
| 12/29/2005 | US20050287648 Protein Transducing Domain/Deaminase Chimeric Proteins, Related Compounds, and Uses Thereof |
| 12/29/2005 | US20050287618 Labeling or detecting of immobilized poly(amino acids), including peptides, polypeptides and proteins, on membranes and other solid supports; |
| 12/28/2005 | EP1608967A2 Compositions and methods for the diagnosis and treatment of tumor |
| 12/28/2005 | EP1608688A2 Branched water-soluble polymers and their conjugates |
| 12/28/2005 | EP1123114B1 Virus-like particles for the induction of autoantibodies |
| 12/28/2005 | EP1025129B1 Monoclonal antibody to alpha2-macroglobulin and its use for detecting glucan |
| 12/28/2005 | EP0716609B1 Methods and compositions for stimulating and inhibiting tgf-beta activity |
| 12/28/2005 | CN1233657C Anticoagulation raticide immunogen synthesis method |
| 12/27/2005 | US6979442 granulocyte colony stimulating factor (G-CSF) and a stabilizing buffer; sustained release; for preventing or treating infections in mammals |
| 12/22/2005 | WO2005121181A1 Multi-drop tree branching polyethylene glycol-oligopeptides and active derivates and pharmaceutical compounds there of |
| 12/22/2005 | WO2005120564A2 Vaccine compositions and methods |
| 12/22/2005 | WO2005107491A3 Multi-lectin affinity chromatography and uses thereof |
| 12/22/2005 | WO2005096706A3 Antibody to 5'-deoxy-5'-methylthioadenosine and uses thereof |
| 12/22/2005 | WO2004093823A3 Polyethelene glycol link glp-1 compounds |
| 12/22/2005 | US20050283003 Reversible immobilization of arginine-tagged moieties on a silicate surface |
| 12/22/2005 | US20050282222 Nematode PAN and ZP receptor-like sequences |
| 12/22/2005 | CA2569909A1 Vaccine compositions and methods |
| 12/21/2005 | EP1606351A2 Cyanine dye labelling reagents with meso-substitution |
| 12/21/2005 | EP1605897A2 Polyethelene glycol link glp-1 compounds |
| 12/21/2005 | EP1196442B1 Vgf polypeptides and methods of treating vgf-related disorders |
| 12/15/2005 | WO2005118614A1 Methods and compositions for treating neuropathic pain |
| 12/15/2005 | WO2005059100A3 Methods and compositions relating to cystatin c |
| 12/15/2005 | WO2005033267A3 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof |
| 12/15/2005 | WO2004083258A3 Branched water-soluble polymers and their conjugates |
| 12/15/2005 | US20050277160 peptide or a phage recognizing nanographite structures and thus enabling efficient recognition, binding, separation and alignment of nanographite structures such as carbon nanohorns or carbon nanotubes, an artificial protein or a chimeric molecule comprising the above-described peptide bond |
| 12/15/2005 | US20050277155 Method of immobilizing probes, in particular for producing biochips |
| 12/15/2005 | CA2568750A1 Compositions and methods for treatment of neovascular diseases |
| 12/14/2005 | EP1604684A1 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
| 12/14/2005 | EP1604032A2 Method for detecting prognosis of cancer |
| 12/14/2005 | EP1603931A2 Methods of evaluating glycomolecules for enhanced activities |
| 12/14/2005 | EP1044375B1 Method comprising capture molecule fixed on disc surface |
| 12/14/2005 | EP0865486B1 Stable biotinylated biomolecule composition and methods |